"By combining advanced testing with expert nurse support, the service helps deliver better outcomes for employees, strong engagement and productivity for businesses, and sustainable cost control for employers, while providing compassionate, world-class care at every level"
- Ian Talbot - CEO at Healix Health
Healix Health has launched a new Precision Cancer Service in partnership with Further, a global healthcare solutions provider. The initiative combines advanced genomic testing with clinical expertise to improve outcomes for employees affected by cancer while helping employers manage costs more effectively.
The new service, an extension of Healix’s cancer care pathway, applies precision medicine to ensure employees receive the right treatment at the right time. Research shows this approach can reduce the risk of serious misdiagnoses by up to 38%, cut treatment costs by 35%, and improve overall survival rates.
By integrating precision medicine into workplace healthcare, Healix aims to support employees and their families through every stage of their cancer journey, reducing time away from work and minimising unnecessary side effects. The launch underlines Healix’s focus on delivering clinically robust, compassionate and continuous care.
Cancer now represents around 30% of private healthcare claims, compared with just 1% twenty years ago, highlighting the growing need for effective, sustainable cancer management strategies.
How the Precision Cancer Service works
The Precision Cancer Service is available for a fixed annual fee per principal member, including spouses and dependents. It supports employees diagnosed with stage 3 or 4 cancer, rare cancers, cancers of unknown primary, and those unresponsive to first-line treatment.
Activation begins with the Healix clinical team, who coordinate access for eligible patients. Further then conducts advanced genomic testing, with results reviewed by an international panel of precision medicine specialists. This panel creates a personalised treatment plan that may include access to relevant clinical trials and considerations for hereditary factors.
Patients receive their results through a consultation with a Further clinical case manager, who offers guidance, supports trial enrolment, and connects them to a genetics pathway for hereditary cancers. Throughout the process, a Healix Health nurse provides consistent support, ensuring patients receive coordinated, person-centred care. This combined approach helps employees manage the physical and emotional challenges of cancer while enabling employers to control high-cost claims.
“Cancer touches every organisation. It’s no longer rare; it’s a reality for any modern workforce, with nearly a third of private healthcare claims costs now related to cancer,” said Ian Talbot, CEO at Healix Health (pictured). “While advances in treatment have improved survival rates, they have also introduced new complexities, rising costs and greater expectations.
“This new service is going to make a big difference to the way employers tackle cancer. By combining advanced testing with expert nurse support, the service helps deliver better outcomes for employees, strong engagement and productivity for businesses, and sustainable cost control for employers, while providing compassionate, world-class care at every level.”
